Impact of social support programme on MDR-TB patients' treatment outcomes Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014
MDR TB treatment results of GFATM program implementation in Tomsk, Russia Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Outbreak of multidrug-resistant TB in a cyber-gaming cafe Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Indicators of rifampicin-resistant TB response in Belarus, 2009-2014 Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
National advisory services for multidrug-resistant tuberculosis (MDRTB) in Europe: an ERS-TBnet survey Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019
Transmission pattern of MDR-TB in Singapore 2005-2015 Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
Tuberculosis (TB) in teenagers-an output of old / new national TB program Source: Eur Respir J 2002; 20: Suppl. 38, 216s Year: 2002
Supporting progress towards the post-2015 targets and regional tuberculosis elimination: a statement of intent from the third meeting of the Asian TB Experts Community Source: Eur Respir J 2015; 45: 1760-1762 Year: 2015
Clinical profile of MDR-TB patients and their early response to DOTS PLUS: An Indian perspective Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013
Cross-border management of tuberculosis cases through an updated ERS/WHO TB consilium Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015
The global response to rifampicin-resistant tuberculosis: Current situation and recent trends Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
Improved treatment outcome of MDR-TB in Eastern Taiwan: Reducing default rate by DOTS Plus Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013
Success of the Tomsk Oblast tuberculosis control program for 2004-2009, the Global Fund grant Source: Annual Congress 2010 - Tuberculosis control Year: 2010
Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Steps of bedaquline implementation in Georgia Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016
Strengthening the DOTS-Plus TB Control Programme in Estonia 2002-2004 (a pilot project for intensified case finding in high-risk groups in the Ida-Virumaa region) Source: Eur Respir J 2005; 26: Suppl. 49, 455s Year: 2005
Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Improvement of TB epidemiological situation in Tomsk Oblast within the MDR-TB treatment program Source: Annual Congress 2008 - Asthma and miscellaneous disorders Year: 2008
Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus – 2009-2010 Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013
Is the sit-to-stand test (STST) a valuable tool for the evaluation of the impact of a pulmonary rehabilitation program (PRP) in COPD? Results from the French cohort rehaeffort from IRSR des Pays de Loire Source: International Congress 2016 – Best abstracts in exercise capacity and testing in chronic lung diseases Year: 2016